Cargando…
FGF23 in Chronic Kidney Disease: Bridging the Heart and Anemia
Fibroblast growth factor 23 (FGF23) is a phosphaturic hormone produced mainly in osteocytes. In chronic kidney disease (CKD) FGF23 levels increase due to higher production, but also as the result of impaired cleavage and reduced excretion from the body. FGF23 has a significant role in disturbed bone...
Autores principales: | Figurek, Andreja, Rroji, Merita, Spasovski, Goce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954184/ https://www.ncbi.nlm.nih.gov/pubmed/36831276 http://dx.doi.org/10.3390/cells12040609 |
Ejemplares similares
-
The Complexity of FGF23 Effects on Cardiomyocytes in Normal and Uremic Milieu
por: Figurek, Andreja, et al.
Publicado: (2021) -
Proteomic Approaches and Potential Applications in Autosomal Dominant Polycystic Kidney Disease and Fabry Disease
por: Rroji, Merita, et al.
Publicado: (2023) -
Phosphate in the Context of Cognitive Impairment and Other Neurological Disorders Occurrence in Chronic Kidney Disease
por: Rroji, Merita, et al.
Publicado: (2022) -
Should We Consider the Cardiovascular System While Evaluating CKD-MBD?
por: Rroji, Merita, et al.
Publicado: (2020) -
Neuropeptide Y as a risk factor for cardiorenal disease and cognitive dysfunction in chronic kidney disease: translational opportunities and challenges
por: Zoccali, Carmine, et al.
Publicado: (2021)